Skip to content
Home
Armis Biopharma® Products
Product Pipeline
News
Leadership Team
Leadership Team
Leadership Team
Management Team
Armis Biopharma® Board of Directors
Armis Biopharma® Scientific Advisory Board
About Us
Employment Opportunities
Contact Us
Policies
Policies
Privacy Policy
Terms of Service
Refund Policy
Home
Armis Biopharma® Products
Product Pipeline
News
Leadership Team
Leadership Team
Management Team
Armis Biopharma® Board of Directors
Armis Biopharma® Scientific Advisory Board
About Us
Employment Opportunities
Contact Us
Policies
Privacy Policy
Terms of Service
Refund Policy
Search
Cart
Item added to your cart
Check out
Continue shopping
Armis Biopharma®
LATEST NEWS
January 22, 2024
Armis Biopharma® Announces the Addition of Two Key Executives to Enhance Commercialization of their Product Portfolio
Read More Here
September 28, 2023
Armis Biopharma® Announces Receipt of a $20.3 Million Contract with the Defense Threat Reduction Agency to Develop Veriox® DECON for Battlefield Wounds
Read More Here
May 31, 2023
Armis Biopharma® Announces 510(k) Clearance for VeriCyn® Wound Wash
Read More Here
December 14, 2022
Veriox® DECON is Shown to Kill Biological Warfare Agent, Anthrax
Read More Here
August 15, 2022
Armis Biopharma® Announces Release of Phase 2 Grant Awardfrom the National Institutes of Health
Read More Here
May 31, 2023
Armis Biopharma® Announces 510(k) Clearance for VeriCyn® Wound Wash
Read More Here
September 23, 2021
Donates ArmiClenz® Disinfectant to Convoy of Hope for Hurricane Ida Victims
Read More Here
November 19, 2020
Armis Biopharma® Announces 510(k) Clearance for VeriFixx™ Small Bone Implant
Read More Here
November 9, 2020
Armis Biopharma® Announces Grant Awardfrom the National Institutes of Health
Read More Here
Choosing a selection results in a full page refresh.
Opens in a new window.
